MYL

Why Mylan N.V. (MYL), GameStop Corp. (GME) and Finish Line Inc (FINL) Are 3 of Today’s Worst Stocks

The end of the trading week couldn't come soon enough for Mylan (MYL), Finish Line (FINL) and GameStop (GME) shareholders.

3 Big Stock Charts for Thursday: Mylan N.V. (MYL), Campbell Soup Company (CPB) and Microsoft Corporation (MSFT)

Microsoft (MSFT) shares are ready to continue higher, while Mylan (MYL) and Campbell Soup (CPB) stock are in troubled territory.

Mylan NV (MYL) Stock Jumps on Strong Q4 Earnings

Mylan NV (MYL) shares grew more than 6% as the pharmaceutical company posted fourth-quarter results that came in ahead of expectations Wednesday.

Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock: Will the Slump End?

The flood of Teva Pharmaceutical's (TEVA) bad news, such as a CEO departure and patent case loses, just keep pummeling TEVA stock.

Why Valeant Pharmaceuticals Intl Inc (VRX) Stock Will Finally Stabilize

Valeant Pharmaceuticals (VRX) is finally getting its house in order. Don't expect VRX stock to explode, but it will get a lift.

3 Earnings Reports Every Investor Should Watch

While I expect the rest of earnings season to be relatively calm, that doesn’t mean there aren’t new things the upcoming reports can tell us.

7 Healthcare Stocks That Will Cripple Your Portfolio

Healthcare is undergoing significant transition, so avoid the weakest ones that are prone to downside risk under the incoming administration.

CVS Health Corp (CVS) to Sell Cheaper Generic Version of EpiPen

CVS Health Corp (CVS) has announced that it is now selling a generic version of EpiPen that is much cheaper than the name brand.

Cigna Corporation (CI) Stops Covering EpiPen by Mylan NV (MYL)

Cigna Corporation (CI) will no longer be covering the expensive EpiPen made by Mylan NV (MYL) now that a generic version is available.

TEVA, MYL Among Six Drug Makers Accused of Price Fixing in U.S.

A pharma price fixing scandal has hit Teva Pharmaceutical Industries Ltd (ADR) and Mylan hard. Here's what you should know about the travesty.

Mylan NV Layoffs: EpiPen Maker MYL Plans Job Cuts, Restructure

EpiPen maker Mylan NV has announced that that the company is launching a restructuring plan that will lead to up to 3,500 losing their jobs.

3 Beaten-Down Generic Drugmakers to Buy

Generic drugmakers Mylan (MYL), Teva (TEVA) and Novartis (NOV) took a hit from DOJ subpoenas on speculation of price-fixing in the industry.

16 Pharmaceuticals Stocks to Sell Now

The overall ratings of 16 Pharmaceuticals stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

13 Pharmaceuticals Stocks to Sell Now

The ratings of 13 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

26 Pharmaceuticals Stocks to Sell Now

The ratings of 26 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Buy the SPDR S&P Biotech (ETF) (XBI) TODAY – Here’s Why

Biotech stocks and the SPDR S&P Biotech ETF (XBI) just shook off a major bugaboo in Hillary Clinton. The XBI ETF will soar as a result.

Valeant Pharmaceuticals Intl Inc (VRX) Stock Enters ‘Survivor Mode’

Valeant Pharmaceuticals (VRX) has to sell the family silver to pay debts, and its business model is under attack. VRX stock might not make it.

3 Stocks to Watch on Tuesday: Hertz Global Holdings, Inc (HTZ), Priceline Group Inc (PCLN) and Mylan NV (MYL)

Hertz (HTZ) is cratering on earnings, Priceline (PCLN) earned a boost off its report and Mylan (MYL) is back in headlines over EpiPen issues.

3 Pharma Stocks That Could Be Gutted If Marijuana Wins

If marijuana initiatives perform well on Election Day, opioid pharma stocks such as MYL, DEPO and INSY could be the big losers.